Abstract
CT-637 Post-Transplant Cyclophosphamide (PTCy) Based Graft Versus Host Disease (GVHD) Prophylaxis is Safe and Effective in Elderly Patients over Age 70 Years Undergoing Allogeneic (Allo) Stem Cell Transplantation (SCT)
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
